Xeris Biopharma Holdings, Inc.

XERS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$91,598$59,285$58,440$71,621
Short-Term Investments$0$0$0$0
Receivables$53,751$53,048$46,330$40,415
Inventory$67,462$67,282$52,690$48,175
Other Curr. Assets$11,206$5,963$6,034$7,451
Total Curr. Assets$224,017$185,578$163,494$167,662
Property Plant & Equip (Net)$27,209$27,687$27,791$28,211
Goodwill$22,859$22,859$22,859$22,859
Intangibles$90,789$93,500$96,211$98,921
Long-Term Investments$0$0$4,123$4,123
Tax Assets$0$0$0$0
Other NC Assets$5,317$5,062$975$1,284
Total NC Assets$146,174$149,108$151,959$155,398
Other Assets$0$0$0$0
Total Assets$370,191$334,686$315,453$323,060
Liabilities
Payables$6,527$9,462$6,352$2,290
Short-Term Debt$6,194$6,156$18,076$21,182
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$103,479$79,553$70,644$76,971
Total Curr. Liab.$116,200$95,171$95,072$100,443
LT Debt$31,991$251,067$250,675$250,265
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$222,861$7,752$4,834$1,967
Total NC Liab.$254,852$258,819$255,509$252,232
Other Liabilities$0$0$0$0
Cap. Leases$0$38,597$38,987$39,339
Total Liabilities$371,052$353,990$350,581$352,675
Equity
Pref Stock$0$0$0$0
Common Stock$17$16$16$15
Retained Earnings-$682,388-$683,009-$681,081-$671,861
AOCI-$25-$24-$25-$25
Other Equity$681,535$663,713$645,962$642,256
Total Equity-$861-$19,304-$35,128-$29,615
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$370,191$334,686$315,453$323,060
Net Debt-$53,413$197,938$210,311$199,826
Xeris Biopharma Holdings, Inc. (XERS) Financial Statements & Key Stats | AlphaPilot